Press release
How is the Demand for Human Papillomavirus Testing impacting the Medical Devices Industry?
According to the latest Arizton's market research report, the human papillomavirus testing market size to cross USD 1.1 million by 2025, growing at a CAGR of over 12% during the forecast period.Human Papillomavirus Testing Market Growth
The overall growth of the global human papillomavirus testing market is mainly attributed to the increased procurement of latest-generation human papillomavirus testing analyzers and test kits. With the high prevalence of HPV-related infections and cancers specifically cervical cancer that needs accurate, sensitive, and effective diagnosis of HPV genotypes responsible for various cancers is fueling the growth of the market. The human papillomavirus testing market has witnessed significant growth both in terms of revenue and sales volume, especially due to the growing prevalence of cervical, vaginal, and other HPV associated cancer.
Increasing Demand for HPV Co-Testing
FDA approved the use of human papillomavirus testing in association with routine cervical cytology as a screening technique for cervical cancer with the rising incidence of cervical cancer globally. Human papillomavirus co-testing offers increased sensitivity for detecting high-risk HPV and it also offers increased cost savings. With greater sensitivity, the combination pap and HPV testing are likely to become the preferred screening strategy in years to come. Compared to cytology test alone, human papillomavirus co-testing showed improved sensitivity (95% to 99%) for the detection of high-grade cervical dysplasia.
Get your sample today!
https://www.arizton.com/market-reports/human-papillomavirus-testing-market-hpv-testing-market
Key Offerings:
Market Size & Forecast by Revenue | 2019−2025
Market Dynamics – Leading trends, growth drivers, restraints, and investment opportunities
Segmentation – A detailed analysis by products, applications, end-user, and geography
Competitive Landscape – 4 Key Company Profiles and 16 Other Prominent Vendors
Human Papillomavirus Testing Market – Geography Analysis
Human papillomavirus testing market in North America is expected to witness the highest incremental growth of around USD 351 million during the forecast period. The US is the major revenue contributor in the North American human papillomavirus testing market. North America is an attractive market for the HPV testing market due to high healthcare expenditure in the region. The demand for HPV testing in the region is driven by high awareness, the presence of a large pool of the patient population, a high penetration rate, better product availability, and extensive reach of innovative products. With the increasing cervical cancer patient volume, North America offers tremendous growth opportunities.
Competition Overview
The global human papillomavirus testing market is highly competitive and characterized by the presence of many global, regional, and local players. Human papillomavirus testing vendors, especially global players, are increasingly focusing on pursuing inorganic growth strategies such as acquisitions and strategic partnerships to expand their presence, enhance product portfolio, and improve expertise in the market. The key players have also been actively focusing on the development and commercialization of technologically advanced human papillomavirus testing products. Human papillomavirus testing companies have a wide geographic footprint, diversified product portfolio, and a strong focus on innovation and research activities.
Looking for more information? Click Here: https://www.arizton.com/market-reports/human-papillomavirus-testing-market-hpv-testing-market
Source: https://www.arizton.com/news/press-release/human-papillomavirus-testing-industry-share
About Arizton Advisory & Intelligence
Arizton Advisory and Intelligence is an innovation and quality-driven firm, which offers cutting-edge research solutions to clients across the world. We excel in providing comprehensive market intelligence reports and advisory and consulting services.
Arizton has gained a paramount standpoint in the market research arena as it offers top of the line solutions to clients to assess market landscape and to finalize fool proof business strategies. We are committed to provide inclusive market research reports and consulting services to clients from diversified industries including –Consumer Goods & Retail Technology, Automotive and Mobility, Smart Tech, Healthcare and Lifesciences, Industrial Machinery, Chemicals and Materials, IT and Media, Logistics and Packaging
Arizton comprises a team of exuberant and well-experienced analysts who have mastered in generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.
Arizton Advisory & Intelligence
Chicago, Illinois, 60605
Mail: enquiry@arizton.com
Call: +1-312-235-2040/+1 302 469 0707
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release How is the Demand for Human Papillomavirus Testing impacting the Medical Devices Industry? here
News-ID: 2220525 • Views: …
More Releases for HPV
Human Papillomavirus (HPV) Vaccine: Core Growth Enabler in the Rising Prevalence …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Human Papillomavirus (HPV) Vaccine Industry Market Size Be by 2025?
The market size for the Human Papillomavirus (HPV) vaccine has seen a swift expansion in the past few years. The market is projected to inflate from $5.8 billion in 2024 to $6.57 billion in 2025, marking…
Global Human Papillomavirus (HPV) Vaccine Market Report 2025: Insights, Drivers …
The Global Human Papillomavirus (HPV) Vaccine Market size reached US$ 3,043.19 Million in 2024 and is expected to reach US$ 12,361.15 Million by 2033, growing at a CAGR of 16.9% during the forecast period 2025-2033.
The Human Papillomavirus (HPV) Vaccines Market Report by DataM Intelligence offers comprehensive insights into the latest market trends, key growth drivers, and emerging challenges. Crafted to support smarter and faster decision-making, our reports blend in-depth data…
Rising Prevalence Of HPV-Related Diseases Sparks Surge In Human Papillomavirus ( …
The Human Papillomavirus (HPV) Vaccine Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Human Papillomavirus (HPV) Vaccine Market Size During the Forecast Period?
The market size for the human papillomavirus (HPV) vaccine has seen swift growth in the past few years. The…
HPV Vaccines Market 2020-2026 - COVID19 Impact On HPV Vaccines Industry | Top Ke …
HPV Vaccines Market Size, Share & Industry Analysis, By Type (Bivalent and Polyvalent), By Disease Indication (HPV Associated Cancer and Genital Warts), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers, and Others) and Geography Forecast, 2019-2026.
Get Sample Copy Of Report To Know The Impact of Covid19 on this Industry: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/human-papillomavirus-hpv-vaccines-market-101962
Top Key Players: GSK, Merck.
An Overview of the Impact of COVID-19 on HPV Vaccines Market:
The emergence of COVID-19 has brought…
HPV Testing & PAP Test Market by Test Type (HPV Testing, Follow-up HPV Testing, …
Global HPV Testing & PAP Test Market was valued at USD XX billion in the year 2017. Global HPV Testing & PAP Test market is further estimated to grow at a CAGR of XX % from 2018 to reach USD XX billion by the year 2023.
Get Free Access to Sample Report @ https://genesismarketinsights.com/Sample_Request/GENRE385
In the Global HPV Testing & PAP Test Market, by region, North America holds the highest market share…
Cytology and HPV Testing Market: Disparate Levels of Awareness among Patients Re …
Over the years, the level of awareness among the global population regarding the various types of cancer has increased tremendously. The significance of early detection and diagnosis is not lost on them, resulting in the increased adoption of screening tests such as cytology and human papillomavirus (HPV) testing.
The global market for cytology and HPV testing is presented with a host of sustained growth opportunities arising mainly from several emerging economies,…